The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Viral Inactivation-Global Market Insights and Sales Trends 2025
Synopsis
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
The global Viral Inactivation market size is expected to reach US$ 989.3 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Inactivation in various end use industries. The expanding demands from the Blood and Blood Products, Cellular and Gene Therapy Products, Stem Cell Products and Tissue and Tissue Products, are propelling Viral Inactivation market. Kits and Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Inactivation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Inactivation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Inactivation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Inactivation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Inactivation covered in this report include Danaher, Merck, Parker Hannifin, Sartorius, SGS, Charles River Laboratories International, Clean Cells, Rad Source Technologies and Texcell, etc.
The global Viral Inactivation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Global Viral Inactivation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Inactivation market, Segment by Type:
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Global Viral Inactivation market, by Application
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Inactivation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
The global Viral Inactivation market size is expected to reach US$ 989.3 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Inactivation in various end use industries. The expanding demands from the Blood and Blood Products, Cellular and Gene Therapy Products, Stem Cell Products and Tissue and Tissue Products, are propelling Viral Inactivation market. Kits and Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Inactivation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Inactivation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Inactivation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Inactivation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Inactivation covered in this report include Danaher, Merck, Parker Hannifin, Sartorius, SGS, Charles River Laboratories International, Clean Cells, Rad Source Technologies and Texcell, etc.
The global Viral Inactivation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Global Viral Inactivation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Inactivation market, Segment by Type:
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Global Viral Inactivation market, by Application
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Inactivation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Viral Inactivation
1.1 Viral Inactivation Market Overview
1.1.1 Viral Inactivation Product Scope
1.1.2 Viral Inactivation Market Status and Outlook
1.2 Global Viral Inactivation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Viral Inactivation Market Size by Region (2018-2029)
1.4 Global Viral Inactivation Historic Market Size by Region (2018-2023)
1.5 Global Viral Inactivation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Viral Inactivation Market Size (2018-2029)
1.6.1 North America Viral Inactivation Market Size (2018-2029)
1.6.2 Europe Viral Inactivation Market Size (2018-2029)
1.6.3 Asia-Pacific Viral Inactivation Market Size (2018-2029)
1.6.4 Latin America Viral Inactivation Market Size (2018-2029)
1.6.5 Middle East & Africa Viral Inactivation Market Size (2018-2029)
2 Viral Inactivation Market by Type
2.1 Introduction
2.1.1 Kits and Reagents
2.1.2 Services
2.1.3 Viral Inactivation Systems and Accessories
2.2 Global Viral Inactivation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Viral Inactivation Historic Market Size by Type (2018-2023)
2.2.2 Global Viral Inactivation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Inactivation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Viral Inactivation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Viral Inactivation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Viral Inactivation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Viral Inactivation Revenue Breakdown by Type (2018-2029)
3 Viral Inactivation Market Overview by Application
3.1 Introduction
3.1.1 Blood and Blood Products
3.1.2 Cellular and Gene Therapy Products
3.1.3 Stem Cell Products
3.1.4 Tissue and Tissue Products
3.1.5 Vaccines and Therapeutics
3.2 Global Viral Inactivation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Viral Inactivation Historic Market Size by Application (2018-2023)
3.2.2 Global Viral Inactivation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Inactivation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Viral Inactivation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Viral Inactivation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Viral Inactivation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Viral Inactivation Revenue Breakdown by Application (2018-2029)
4 Viral Inactivation Competition Analysis by Players
4.1 Global Viral Inactivation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Inactivation as of 2022)
4.3 Date of Key Players Enter into Viral Inactivation Market
4.4 Global Top Players Viral Inactivation Headquarters and Area Served
4.5 Key Players Viral Inactivation Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Inactivation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Danaher
5.1.1 Danaher Profile
5.1.2 Danaher Main Business
5.1.3 Danaher Viral Inactivation Products, Services and Solutions
5.1.4 Danaher Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.1.5 Danaher Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Viral Inactivation Products, Services and Solutions
5.2.4 Merck Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Parker Hannifin
5.3.1 Parker Hannifin Profile
5.3.2 Parker Hannifin Main Business
5.3.3 Parker Hannifin Viral Inactivation Products, Services and Solutions
5.3.4 Parker Hannifin Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.3.5 Sartorius Recent Developments
5.4 Sartorius
5.4.1 Sartorius Profile
5.4.2 Sartorius Main Business
5.4.3 Sartorius Viral Inactivation Products, Services and Solutions
5.4.4 Sartorius Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.4.5 Sartorius Recent Developments
5.5 SGS
5.5.1 SGS Profile
5.5.2 SGS Main Business
5.5.3 SGS Viral Inactivation Products, Services and Solutions
5.5.4 SGS Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.5.5 SGS Recent Developments
5.6 Charles River Laboratories International
5.6.1 Charles River Laboratories International Profile
5.6.2 Charles River Laboratories International Main Business
5.6.3 Charles River Laboratories International Viral Inactivation Products, Services and Solutions
5.6.4 Charles River Laboratories International Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.6.5 Charles River Laboratories International Recent Developments
5.7 Clean Cells
5.7.1 Clean Cells Profile
5.7.2 Clean Cells Main Business
5.7.3 Clean Cells Viral Inactivation Products, Services and Solutions
5.7.4 Clean Cells Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.7.5 Clean Cells Recent Developments
5.8 Rad Source Technologies
5.8.1 Rad Source Technologies Profile
5.8.2 Rad Source Technologies Main Business
5.8.3 Rad Source Technologies Viral Inactivation Products, Services and Solutions
5.8.4 Rad Source Technologies Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.8.5 Rad Source Technologies Recent Developments
5.9 Texcell
5.9.1 Texcell Profile
5.9.2 Texcell Main Business
5.9.3 Texcell Viral Inactivation Products, Services and Solutions
5.9.4 Texcell Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.9.5 Texcell Recent Developments
5.10 Viral Inactivated Plasma Systems
5.10.1 Viral Inactivated Plasma Systems Profile
5.10.2 Viral Inactivated Plasma Systems Main Business
5.10.3 Viral Inactivated Plasma Systems Viral Inactivation Products, Services and Solutions
5.10.4 Viral Inactivated Plasma Systems Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.10.5 Viral Inactivated Plasma Systems Recent Developments
5.11 Wuxi Pharmatech (Cayman)
5.11.1 Wuxi Pharmatech (Cayman) Profile
5.11.2 Wuxi Pharmatech (Cayman) Main Business
5.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Products, Services and Solutions
5.11.4 Wuxi Pharmatech (Cayman) Viral Inactivation Revenue (US$ Million) & (2018-2023)
5.11.5 Wuxi Pharmatech (Cayman) Recent Developments
6 North America
6.1 North America Viral Inactivation Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Viral Inactivation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Inactivation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Inactivation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Inactivation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Inactivation Market Dynamics
11.1 Viral Inactivation Industry Trends
11.2 Viral Inactivation Market Drivers
11.3 Viral Inactivation Market Challenges
11.4 Viral Inactivation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
